Affordable HIV prevention injection to be offered in the MENA
|
A twice-yearly generic HIV prevention drug will be
offered for around $40 in several MENA countries, but many people still have
no access. |
NICE rejects long-acting HIV prevention treatment for NHS use
Lenacapavir, a twice-yearly injection to reduce the risk of HIV infection, should not be routinely available as preventative treatment. View article...